To evaluate the efficacy and safety under field conditions of the new vaccine UBAC® (HIPRA) through a multicenter, randomized, double blinded and placebo-controlled clinical trial.
Efficacy and safety under field conditions of the new vaccine UBAC® against Streptococcus uberis intramammary infections in dairy cows
Publications
Cattle
Appeared in
National Mastitis Council, 2018
Incidence of animals with S. uberis CM was significantly lower in UBAC® group than in the Placebo group (Figure 2). Also, differences between groups in terms of incidence of animals with S. uberis ScM were not statistically significant.